Hikal has posted strong growth in net profit during the fourth quarter ended March 2016 and its net profit increased by 118 per cent to Rs.22.24 crore from Rs.10.19 crore in the similar period of last year . Its net sales also moved up by 35.7 per cent to Rs.289.79 crore from Rs.213.53 crore. With improvement in profit, its EPS increased to Rs.2.71 from Rs.1.24 in the last period. EBDITA also increased by 32.4 per cent to Rs.59.90 crore from Rs.45.24 crore. The board has declared total dividend of 50 per cent for the year 2015-16.

For the full year ended March 2016, Hikal's net sales improved by 6.2 per cent to Rs.925.65 crore from Rs.871.86 crore in the previous year. Its pharmaceutical sales improved by 5.9 per cent to Rs.569.14 crore from Rs.537.51 crore and that of crop protection products increased by 6.6 per cent to Rs.334.35 crore from Rs.334.35 crore. 

Its net profit moved up marginally by 1.9 per cent to Rs.41.31 crore from Rs.40.52 crore basically due to higher foreign exchange loss of Rs.14.62 crore as compared to Rs.4.60 crore in the previous year. EPS worked out to Rs.5.03 as against Rs.4.93 in the last year.

As against the equity capital of Rs.16.44 crore, its reserves & surplus stood at Rs.547.35 crore. Its long term borrowings increased by 47.2 per cent to Rs.296.61 crore from Rs.201.44 crore.